BCR and chronic myelogenous leukemia, BCR-ABL1 positive: To understand the mechanisms underlying CML persistence, previous studies have mainly focused on cell-intrinsic mechanisms such as BCR/ABL overexpression, Kinase mutations as well as drug influx and efflux regulations [3–5].